A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China
Clinical trial NCT05017480 · COMPLETED
Trial details
- NCT number
- NCT05017480
- Sponsor
- Connect Biopharm LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-31
- Primary completion
- 2022-12-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.